Bettini, E.; De Martin, S.; Mattarei, A.; Pappagallo, M.; Stahl, S.M.; Bifari, F.; Inturrisi, C.E.; Folli, F.; Traversa, S.; Manfredi, P.L.
The N-Methyl-D-Aspartate Receptor Blocker REL-1017 (Esmethadone) Reduces Calcium Influx Induced by Glutamate, Quinolinic Acid, and Gentamicin. Pharmaceuticals 2022, 15, 882.
https://doi.org/10.3390/ph15070882
AMA Style
Bettini E, De Martin S, Mattarei A, Pappagallo M, Stahl SM, Bifari F, Inturrisi CE, Folli F, Traversa S, Manfredi PL.
The N-Methyl-D-Aspartate Receptor Blocker REL-1017 (Esmethadone) Reduces Calcium Influx Induced by Glutamate, Quinolinic Acid, and Gentamicin. Pharmaceuticals. 2022; 15(7):882.
https://doi.org/10.3390/ph15070882
Chicago/Turabian Style
Bettini, Ezio, Sara De Martin, Andrea Mattarei, Marco Pappagallo, Stephen M. Stahl, Francesco Bifari, Charles E. Inturrisi, Franco Folli, Sergio Traversa, and Paolo L. Manfredi.
2022. "The N-Methyl-D-Aspartate Receptor Blocker REL-1017 (Esmethadone) Reduces Calcium Influx Induced by Glutamate, Quinolinic Acid, and Gentamicin" Pharmaceuticals 15, no. 7: 882.
https://doi.org/10.3390/ph15070882
APA Style
Bettini, E., De Martin, S., Mattarei, A., Pappagallo, M., Stahl, S. M., Bifari, F., Inturrisi, C. E., Folli, F., Traversa, S., & Manfredi, P. L.
(2022). The N-Methyl-D-Aspartate Receptor Blocker REL-1017 (Esmethadone) Reduces Calcium Influx Induced by Glutamate, Quinolinic Acid, and Gentamicin. Pharmaceuticals, 15(7), 882.
https://doi.org/10.3390/ph15070882